Diffuse large B cell lymphoma epidemiology and demographics: Difference between revisions
Mahshid |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diffuse large B cell lymphoma}} | {{Diffuse large B cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} {{AHS}} | ||
==Overview== | ==Overview== | ||
Diffuse large B cell lymphoma is the most common type of [[non-Hodgkin lymphoma]] among adults,<ref name="Blood1997">{{cite journal |pmid=9166827 |year=1997 |title=A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project |journal=Blood |volume=89 |issue=11 |pages=3909–18 |url=http://www.bloodjournal.org/content/89/11/3909 }}</ref> with an annual [[Incidence (epidemiology)|incidence]] of 7–8 cases per 100,000 people per year.<ref name="Morton2006">{{cite journal |doi=10.1182/blood-2005-06-2508 |pmid=16150940 |pmc=1895348 |title=Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 |journal=Blood |volume=107 |issue=1 |pages=265–76 |year=2006 |last1=Morton |first1=L. M. |last2=Wang |first2=S. S. |last3=Devesa |first3=S. S. |last4=Hartge |first4=P |last5=Weisenburger |first5=D. D. |last6=Linet |first6=M. S. }}</ref><ref name="Smith2011">{{cite journal |doi=10.1038/bjc.2011.450 |pmid=22045184 |pmc=3242607 |title=Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network |journal=British Journal of Cancer |volume=105 |issue=11 |pages=1684–92 |year=2011 |last1=Smith |first1=A |last2=Howell |first2=D |last3=Patmore |first3=R |last4=Jack |first4=A |last5=Roman |first5=E }}</ref> This cancer occurs primarily in older individuals, with a median age of diagnosis at approximately 70 years of age,<ref name="Smith2011" /> though it can also occur in children and young adults in rare cases.<ref name="Smith2010">{{cite journal |doi=10.1111/j.1365-2141.2009.08010.x |pmid=19958356 |pmc=3066245 |title=The Haematological Malignancy Research Network (HMRN): A new information strategy for population based epidemiology and health service research |journal=British Journal of Haematology |volume=148 |issue=5 |pages=739–53 |year=2010 |last1=Smith |first1=Alexandra |last2=Roman |first2=Eve |last3=Howell |first3=Debra |last4=Jones |first4=Richard |last5=Patmore |first5=Russell |last6=Jack |first6=Andrew |author7=Haematological Malignancy Research Network }}</ref> | Diffuse large B cell lymphoma is the most common type of [[non-Hodgkin lymphoma]] among adults,<ref name="Blood1997">{{cite journal |pmid=9166827 |year=1997 |title=A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project |journal=Blood |volume=89 |issue=11 |pages=3909–18 |url=http://www.bloodjournal.org/content/89/11/3909 }}</ref> with an annual [[Incidence (epidemiology)|incidence]] of 7–8 cases per 100,000 people per year.<ref name="Morton2006">{{cite journal |doi=10.1182/blood-2005-06-2508 |pmid=16150940 |pmc=1895348 |title=Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 |journal=Blood |volume=107 |issue=1 |pages=265–76 |year=2006 |last1=Morton |first1=L. M. |last2=Wang |first2=S. S. |last3=Devesa |first3=S. S. |last4=Hartge |first4=P |last5=Weisenburger |first5=D. D. |last6=Linet |first6=M. S. }}</ref><ref name="Smith2011">{{cite journal |doi=10.1038/bjc.2011.450 |pmid=22045184 |pmc=3242607 |title=Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network |journal=British Journal of Cancer |volume=105 |issue=11 |pages=1684–92 |year=2011 |last1=Smith |first1=A |last2=Howell |first2=D |last3=Patmore |first3=R |last4=Jack |first4=A |last5=Roman |first5=E }}</ref> This cancer occurs primarily in older individuals, with a median age of diagnosis at approximately 70 years of age,<ref name="Smith2011" /> though it can also occur in children and young adults in rare cases.<ref name="Smith2010">{{cite journal |doi=10.1111/j.1365-2141.2009.08010.x |pmid=19958356 |pmc=3066245 |title=The Haematological Malignancy Research Network (HMRN): A new information strategy for population based epidemiology and health service research |journal=British Journal of Haematology |volume=148 |issue=5 |pages=739–53 |year=2010 |last1=Smith |first1=Alexandra |last2=Roman |first2=Eve |last3=Howell |first3=Debra |last4=Jones |first4=Richard |last5=Patmore |first5=Russell |last6=Jack |first6=Andrew |author7=Haematological Malignancy Research Network }}</ref> | ||
Revision as of 22:28, 23 July 2018
|
Diffuse large B cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diffuse large B cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Diffuse large B cell lymphoma epidemiology and demographics |
|
FDA on Diffuse large B cell lymphoma epidemiology and demographics |
|
CDC on Diffuse large B cell lymphoma epidemiology and demographics |
|
Diffuse large B cell lymphoma epidemiology and demographics in the news |
|
Blogs on Diffuse large B cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Diffuse large B cell lymphoma |
|
Risk calculators and risk factors for Diffuse large B cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2] Anila Hussain, MD [3]
Overview
Diffuse large B cell lymphoma is the most common type of non-Hodgkin lymphoma among adults,[1] with an annual incidence of 7–8 cases per 100,000 people per year.[2][3] This cancer occurs primarily in older individuals, with a median age of diagnosis at approximately 70 years of age,[3] though it can also occur in children and young adults in rare cases.[4]
Incidence
Diffuse large B cell lymphoma is the most common type of non-Hodgkin lymphoma among adults,[1] with an annual incidence of 7–8 cases per 100,000 people per year in the United States.[2][3]
Age
This cancer occurs primarily in older individuals, with a median age of diagnosis at approximately 70 years of age,[3] though it can also occur in children and young adults in rare cases.[4]
References
- ↑ 1.0 1.1 "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project". Blood. 89 (11): 3909–18. 1997. PMID 9166827.
- ↑ 2.0 2.1 Morton, L. M.; Wang, S. S.; Devesa, S. S.; Hartge, P; Weisenburger, D. D.; Linet, M. S. (2006). "Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001". Blood. 107 (1): 265–76. doi:10.1182/blood-2005-06-2508. PMC 1895348. PMID 16150940.
- ↑ 3.0 3.1 3.2 3.3 Smith, A; Howell, D; Patmore, R; Jack, A; Roman, E (2011). "Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network". British Journal of Cancer. 105 (11): 1684–92. doi:10.1038/bjc.2011.450. PMC 3242607. PMID 22045184.
- ↑ 4.0 4.1 Smith, Alexandra; Roman, Eve; Howell, Debra; Jones, Richard; Patmore, Russell; Jack, Andrew; Haematological Malignancy Research Network (2010). "The Haematological Malignancy Research Network (HMRN): A new information strategy for population based epidemiology and health service research". British Journal of Haematology. 148 (5): 739–53. doi:10.1111/j.1365-2141.2009.08010.x. PMC 3066245. PMID 19958356.